The role of PDK1 in promoting breast cancer susceptibility by activating beta -catenin signaling and modulating the proliferative activity of stem cell antigen-1 (Sca-1)

2006 2006

Other formats: Order a copy

Abstract (summary)

PDK1, a 63 KDa serine/threonine kinase, serves as the master switch downstream of growth factor receptor-coupled PI3-Kinase activation. PDK1 phosphorylates and activates AGC kinases, such as Akt and PKC, that promote cell survival, tumorigenesis, invasion, and drug resistance. Our laboratory has previously shown PDK1 to be oncogenic in mouse mammary epithelial cells, forming highly invasive tumors as isografts. This study shows that PDK1 overexpression in human mammary epithelial cells increases EGF-dependent growth and activates beta-catenin signaling in breast cancer cells. PDK1 serves as a novel regulator of stem cell antigen-1 (Sca-1), a glycosylphosphotidylinositol (GPI) anchored protein commonly used as a marker for stem cells. The PI3-Kinase signal cascade has been implicated in the regulation and maintenance of stem and progenitor cells. PDK1-mediated transformation is associated with beta-catenin signal pathway activation and a concomitant decrease in the putative tumor suppressor caveolin-1. Activation of the Wnt pathway promotes tumorigenesis, involving an expansion in the Sca-1+mammary progenitor cells. Furthermore, loss of caveolin-1 and the lipid phosphatase PTEN, the major negative regulator of PI3-Kinase/PDK1 signaling, has also been implicated in a similar expansion of stem cells and tumorigenesis. In cell lines derived from carcinogen-induced tumors, I show that PDK1 regulates Sca-1 expression and promoter activity, independent of IFNgamma stimulation. Dysregulation of interferon signaling occurred downstream of the IFNgamma receptor, shown when dominant negative STAT1 inhibited Sca-1 promoter and KDPDK1 reduced STAT1 levels. Furthermore, treatment of tumor cells with Sca-1 blocking antibody or siRNA decreased cell growth by inducing a G2/M block. Overall, I show that PDK1 plays a critical role in promoting breast cancer susceptibility by activating beta-catenin signaling and modulating the proliferative activity of Sca-1. Targeting PDK1 for cancer therapy would not only target growth factor-mediated signaling, but also a population of Sca-1+cancer stem and early progenitor cells.

Indexing (details)

Molecular biology;
Cellular biology
0307: Molecular biology
0379: Cellular biology
Identifier / keyword
Biological sciences; Beta-catenin; Breast cancer; PDK1; Stem cell antigen-1
The role of PDK1 in promoting breast cancer susceptibility by activating beta -catenin signaling and modulating the proliferative activity of stem cell antigen-1 (Sca-1)
Tallapragada, Sruthi
Number of pages
Publication year
Degree date
School code
DAI-B 68/07, Dissertation Abstracts International
Place of publication
Ann Arbor
Country of publication
United States
Glazer, Robert I.
Georgetown University Medical Center
University location
United States -- District of Columbia
Source type
Dissertations & Theses
Document type
Dissertation/thesis number
ProQuest document ID
Database copyright ProQuest LLC; ProQuest does not claim copyright in the individual underlying works.
Document URL
Access the complete full text

You can get the full text of this document if it is part of your institution's ProQuest subscription.

Try one of the following:

  • Connect to ProQuest through your library network and search for the document from there.
  • Request the document from your library.
  • Go to the ProQuest login page and enter a ProQuest or My Research username / password.